规章制度
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
美国食品药品管理局
MHRA
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO清单
临床试验
美国临床试验注册处
欧盟临床试验注册处
制药公司
临床研究实验室
服务公司
Clinical Research Events
刊物
研究人员
工作
刊物
新闻
此页面是自动翻译的,不保证翻译的准确性。请参阅
英文版
对于源文本。
ICH GCP
美国临床试验注册处
Search trials
状况或疾病:
干预/治疗:
赞助:
地点:
仅限招募,尚未招募研究
从不吸烟的临床试验
总计0个结果
什么都没找到
赞助者和合作者
Resonance Health
SwanBio Therapeutics, Inc.
ResMed Canada Inc.
AsyutUniversity
Greater Baltimore Medical Center
HYLAB, Physiopathologie de l'exercice
Antonio Martín Duce
arsany botros saleh
Calvary Health Care Bethlehem
Providence St. Vincent Department of Medicine
QuintilesIMS, Inc.
Xu Hong
Zhigang Li
ITE College West
Mustafakemalpasa State Hospital
King Saud Bin Abdulaziz University for Health Sciences
Mokpo National University
people's hospital of Guang'an
Japan Clinical Cancer Research Organization
Alliance for Cancer Gene Therapy
查看完整清单
医疗条件
免疫缺陷
侧卧位
睾丸未降
遗传性多发性骨软骨瘤
负型;精神分裂症
Terrorism
先天性斜颈
Type 1 Diabetes in Children
围产期抑郁症 (PPD)
花粉过敏
库欣综合征的骨质疏松症
热消融
流产,早期
粘多糖贮积症 VII
杂音,心脏
患者激活
不可靠的胎儿状态
腹腔镜进入技术
高血压前期
威尔逊病
查看完整清单
药物干预
优泌乐®
羟考酮
布瓦西坦 (BRV) 干糖浆
盐酸多西环素
RAPA114
VX-121(悬挂)
OKI-179
非格司亭
Trastuzumab
PF-04965842
复方阿齐米特恩替瑞片
VVN461 眼用溶液 1.0%
I 臂(髂腰肌平面阻滞组)
瑞士法郎5993
克唑替尼
己酮可可碱
异烟肼、利福平、吡嗪酰胺和乙胺丁醇
SDP-4 滴眼液 (3.0%)
马瓦卡姆腾
LUM/IVA
查看完整清单
CROs by country
Contract Research Organizations in Australia
Contract Research Organizations in Austria
Contract Research Organizations in Chile
Contract Research Organizations in Czech Republic
Contract Research Organizations in Georgia
Contract Research Organizations in Greece
Contract Research Organizations in Israel
Contract Research Organizations in Myanmar
Contract Research Organizations in Portugal
Contract Research Organizations in Rwanda
Contract Research Organizations in Spain
Contract Research Organizations in Switzerland
Contract Research Organizations in Ukraine
CRO list by country
CROs in Angola
SGS
All CROs in Angola
3
✕
GOOD CLINICAL PRACTICE NETWORK
订阅以接收监管更新和行业新闻的通知!
订阅
GOOD CLINICAL PRACTICE NETWORK
订阅以接收监管更新和行业新闻的通知!
订阅
订阅